Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
KYMR
#931
Kymera Therapeutics, Inc. - Common Stock
118.1
5
USD
-0.02%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-1.73%
Monthly Change
+11.82%
6 month change
+32.40%
Year Change
+99.92%
Previous Close
120.2
3
Open
118.2
1
Low
118.1
5
High
118.2
1
Volume
147
Markets
US Stock Market
Healthcare
Biotechnology
KYMR
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Documents
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
44.81 M
51.7 M
55.18 M
61.11 M
64.94 M
81.64 M
83.15 M
Valuation ratios
Enterprise value
2.75 B
3.23 B
1.3 B
1.44 B
2.49 B
6 B
9.95 B
Price to earnings ratio
—
—
-8.66
-10.06
-13.5
-21.09
-37.27
Price to sales ratio
—
—
28.61
18.83
64.14
167.66
112.15
Price to cash flow ratio
—
—
-8.75
-14.39
-15.52
-28.23
-47.28
Price to book ratio
—
—
2.73
3.75
3.61
4.16
2
Enterprise value to EBITDA ratio
-61.68
-32.96
-8.23
-8.89
-8.27
-15.77
-22.26
Profitability ratios
Return on assets %
-0.09
-0.17
-0.26
-0.26
-0.23
-0.18
-0.04
Return on equity %
-0.16
-0.22
-0.32
-0.37
-0.27
-0.2
-0.04
Return on invested capital %
-65.97
-160.54
-290.93
—
—
-153.83
—
Gross margin %
100
100
100
100
0
0
0
Operating margin %
-136.05
-138.03
-344.37
-210.62
-555.82
-891.07
-116.32
EBITDA margin %
-130.87
-134.74
-338.02
-206.08
-640.16
-969.87
-213.2
Net margin %
-133.96
-137.6
-330.6
-186.99
-475.57
-794.04
-94.17
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
2.73
4.88
5.88
4.73
7.53
10.47
10.34
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.07
0.13
0.08
0.13
0.06
0.02
0.04
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
-2.84
-1.76
-2.59
-2.76
-2.56
EBIT per share
—
—
-2.99
-2.84
-4.11
-4.6
-4.93
EBITDA per share
—
—
-2.93
-2.78
-4.02
-4.5
-4.84
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
—
7.55
6.42
6.51
10.04
7.04
Net current asset value per share
—
—
7.78
6.94
6.8
10.31
7.51
Tangible book value per share
—
—
9.09
6.77
11.14
18.7
15.37
Working capital per share
—
—
6.45
5.48
5.9
9.33
6.78
Book value per share
—
—
9.09
6.77
11.14
18.7
15.37
News
Analysts See Drastic Change For This Particular Part Of Healthcare
KYMR Q2 Earnings and Revenues Top Estimates on Gilead, Sanofi Payments
Kymera Therapeutics, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:KYMR) 2026-08-05
Kymera Therapeutics, Inc. (KYMR) Q2 2026 Earnings Call Transcript
Kymera Therapeutics, Inc. (KYMR) Reports Q2 Loss, Tops Revenue Estimates
Is Kymera Therapeutics Poised for a Breakthrough With KT-621?
Tracking Baker Brothers Portfolio: Q1 2026 Update
Kymera Therapeutics: Why It May Be Time To Jump On The Bandwagon (Upgrade) (NASDAQ:KYMR)
Kymera: Building Toward A Defining 2H26 Moment (NASDAQ:KYMR)
KYMR Stock Soars 51% YTD on Progress of Atopic Dermatitis Drug
Kymera Jumps 17% on Early Enrollment Completion in Skin Disease Study
Strength Seen in Kymera Therapeutics (KYMR): Can Its 16.6% Jump Turn into More Strength?